Skip to main content

Hemoglobin (Hb), Fetal, Quantitative

CPT

83020

Synonyms
  • Fetal Hemoglobin
  • Hb F
  • Hemoglobin F Quantitation

Test Details

Methodology

Capillary electrophoresis (CE)

Result Turnaround Time

4 - 6 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Test Includes

Capillary electrophoresis (CE) is performed initially. If an abnormal hemoglobin is detected, appropriate testing will be performed at an additional charge.

Use

This test is used to evaluate hemoglobinopathies, hemolytic anemia; diagnose hereditary persistence of fetal hemoglobin; diagnose thalassemia; and evaluate sickling hemoglobins.

Custom Additional Information

Fetal hemoglobin is formed of two α-chains and two γ-chains. It is the major hemoglobin during fetal life. Hb F levels decrease after birth by about 3% to 4% per week. In two to three weeks, fetal hemoglobin is about 65%. By six months of age, fetal hemoglobin is <2% of the total hemoglobin. See graph. The oxygen dissociation curve of Hb F is shifted to the left as compared with normal Hb A. This may be due to decreased binding of 2,3-DPG by Hb F (γ-chains). This facilitates placental oxygen transfer. With erythroblastosis fetalis and anoxic states of the newborn; however, Hb F is proportionally lower than in a normal newborn. Some 15 inherited abnormalities of γ-chain structure have been described1 but most are without clinical significance (fetal Hb normally forms <2% of total hemoglobin). An exception is Hb F Poole, which has been reported as a cause of hemolytic disease of the newborn.2

Nonmalignant Conditions Associated With Increased Proportions of Hb F
ConditionHb F Value (%)
Anemias 
Aplastic anemia (both congenital and acquired)5−25
Pernicious anemia2−6
Hereditary spherocytosis2−5
Hereditary elliptocytosis2−5
Congenital nonspherocytic hemolytic anemia3−4
Anemia of chronic infection2−3
Anemia of blood loss2−8
Erythropoietic porphyria2−10
Paroxysmal nocturnal hemoglobinuria2−25
Hemoglobinopathies 
Unstable hemoglobins<10
Homozygous Hb S disease<20
Hb Lepore trait<5
Hb Kenya trait6−13
Thalassemias 
β-thalassemia minor<5
β-thalassemia intermedia5−20
β-thalassemia major30−95
α-thalassemia minor∼1
Hb H disease5−15
Hemoglobinopathy-thalassemia interactions 
S/β-thalassemia10−30
E/β-thalassemia10−50
C/β-thalassemia10−30
Hereditary persistence of fetal hemoglobin (HPFH) 
African-type 
heterozygous15−40
homozygous100
Greek-type 
heterozygous10−20
Swiss-type 
heterozygous1−3

In the adult, hereditary persistence of fetal hemoglobin (HPFH) of multiple varieties is associated with varying elevations of Hb F. The homozygous form of HPFH is found only in black individuals. In the heterozygous state, the Hb F level is 15% to 35% in the black type, and 5% to 20% in the Greek type. Homozygous β-thalassemia is associated with Hb F levels <10% to >90%. About 50% of heterozygotes for β-thalassemia have elevated levels around 2%, rarely >5%. The remainder have normal Hb F. Heterozygous S/β-thalassemia may have Hb F in the 5% to 20% range. With homozygous Hb S disease, the level of Hb F varies from 0% to 20%.3 Other conditions associated with elevated Hb F include various anemias: spherocytosis, Fanconi, acquired aplastic, hemolytic hypoplastics, megaloblastic, myelophthisic, and untreated pernicious anemia; all types of leukemia (especially erythroleukemia and juvenile chronic myelogenous leukemia), multiple myeloma and lymphomas, metastatic disease of the bone marrow; pregnancy; miscellaneous disorders reported include infants small for gestational age, infants with chronic intrauterine anoxia with developmental anomalies; during anticonvulsant drug therapy; diabetes; hyper- and hypothyroidism; and macroglobulin. Elevation of Hb F should, then, raise the question of possible underlying disease.

Specimen Requirements

Specimen

Whole blood

Volume

1 mL

Minimum Volume

0.5 mL (Note: This volume does not allow for repeat testing.)

Container

Lavender-top (EDTA) tube

Collection Instructions

To avoid delays in turnaround time, please submit a separate lavender-top tube for each test requiring a lavender-top.

Stability Requirements

TemperaturePeriod
Room temperature14 days
Refrigerated14 days
Frozen14 days
Freeze/thaw cyclesStable x3

Reference Range

See table.

AgePercentage
<7 mNot established
7 m to 1 y0.1% to 6.8%
≥2 y0.0% to 2.0%

Storage Instructions

Refrigerate at 2°C to 8°C.

Patient Preparation

Fasting or fluid restriction is not necessary.

Causes for Rejection

Clotted specmen

Footnotes

1. Weatherall DJ, Clegg JB, Higgs DR, et al. The hemoglobinopathies. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill Information Services Co;1989:2323-2324.
2. Lee-Potter JP, Deacon-Smith RA, Simpkiss MJ, Kamuzora H, Lehmann H. A new cause of haemolytic anaemia in the newborn. A description of an unstable fetal haemoglobin: F Poole, α2 γ2 130 tryptophan yields glycine. J Clin Pathol. 1975 Apr;28(4):317-320.1127124
3. Warth JA, Rucknagel DL. The increasing complexity of sickle cell anemia. Prog Hematol. 1983;13:25-47.6199811

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
121072 Hgb, Fetal, Quant 121692 Hgb F % 32682-7
121072 Hgb, Fetal, Quant 121673 Reflex to HPLC N/A
Order Code121072
Order Code NameHgb, Fetal, Quant
Order Loinc
Result Code121692
Result Code NameHgb F
UofM%
Result LOINC32682-7
Order Code121072
Order Code NameHgb, Fetal, Quant
Order Loinc
Result Code121673
Result Code NameReflex to HPLC
UofM
Result LOINCN/A
Reflex Table for Reflex to HPLC
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 121672 Hgb F by HPLC 121712 Hgb F % 42246-9
Reflex 1
Order Code121672
Order NameHgb F by HPLC
Result Code121712
Result NameHgb F
UofM%
Result LOINC42246-9